Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Akari Therapeutics PLC (AKTX) had Income from Continuous Operations of $-5.30M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-5.30M |
|
-- |
|
-- |
|
$3.23M |
|
$-3.23M |
|
$-1.99M |
|
$-5.21M |
|
$-5.21M |
|
$-5.30M |
|
|
Income from Continuous Operations |
$-5.30M |
$-5.30M |
|
$-5.30M |
|
$-3.23M |
|
$-3.23M |
|
0.84M |
|
0.84M |
|
$-12.72 |
|
$-12.72 |
|
| Balance Sheet Financials | |
$5.46M |
|
-- |
|
$42.43M |
|
$47.89M |
|
$12.35M |
|
-- |
|
$7.21M |
|
$19.56M |
|
$28.33M |
|
$-14.10M |
|
$28.33M |
|
1.13M |
|
| Cash Flow Statement Financials | |
$-10.57M |
|
-- |
|
$13.17M |
|
$2.66M |
|
$5.26M |
|
$2.60M |
|
$2.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.44 |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.70% |
|
37.57% |
|
-11.06% |
|
-18.70% |
|
$25.03 |
|
$-12.56 |
|
$-12.56 |
|